{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:48:50Z","timestamp":1783115330682,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11596-022-2649-6","type":"journal-article","created":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:03:32Z","timestamp":1670054612000},"page":"1201-1212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection"],"prefix":"10.1007","volume":"42","author":[{"given":"Bing-fen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-juan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-hong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"2649_CR1","unstructured":"WHO. Global Tuberculosis Report 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240037021, 2021."},{"issue":"7","key":"2649_CR2","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","volume":"18","author":"G Walzl","year":"2018","unstructured":"Walzl G, McNerney R, du Plessis N, et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis, 2018,18(7):e199\u2013e210","journal-title":"Lancet Infect Dis"},{"issue":"9776","key":"2649_CR3","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","volume":"377","author":"CC Boehme","year":"2011","unstructured":"Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet, 2011,377(9776):1495\u20131505","journal-title":"Lancet"},{"issue":"1","key":"2649_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","volume":"27","author":"M Pai","year":"2014","unstructured":"Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev, 2014,27(1):3\u201320","journal-title":"Clin Microbiol Rev"},{"issue":"RR-5","key":"2649_CR5","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection \u2014 United States, 2010. MMWR Recomm Rep, 2010,59(RR-5): 1\u201325","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2649_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/17476348.2014.852471","volume":"8","author":"M Thillai","year":"2014","unstructured":"Thillai M, Pollock K, Pareek M, et al. Interferon-gamma release assays for tuberculosis: current and future applications. Expert Rev Respir Med, 2014,8(1):67\u201378","journal-title":"Expert Rev Respir Med"},{"issue":"11","key":"2649_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41590-018-0225-9","volume":"19","author":"A Singhania","year":"2018","unstructured":"Singhania A, Wilkinson RJ, Rodrigue M, et al. The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis. Nat Immunol, 2018,19(11):1159\u20131168","journal-title":"Nat Immunol"},{"issue":"7309","key":"2649_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 2010,466(7309):973\u2013977","journal-title":"Nature"},{"issue":"18","key":"2649_CR9","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1056\/NEJMoa1303657","volume":"370","author":"ST Anderson","year":"2014","unstructured":"Anderson ST, Kaforou M, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med, 2014,370(18):1712\u20131723","journal-title":"N Engl J Med"},{"key":"2649_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fimmu.2019.00221","volume":"10","author":"JG Burel","year":"2019","unstructured":"Burel JG, Babor M, Pomaznoy M, et al. Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis. Front Immunol, 2019,10:221","journal-title":"Front Immunol"},{"issue":"8","key":"2649_CR11","doi-asserted-by":"publisher","first-page":"e735","DOI":"10.1371\/journal.pone.0000735","volume":"2","author":"M Streitz","year":"2007","unstructured":"Streitz M, Tesfa L, Yildirim V, et al. Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis. PLoS One, 2007,2(8):e735","journal-title":"PLoS One"},{"issue":"10","key":"2649_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1473-3099(14)70884-9","volume":"14","author":"D Portevin","year":"2014","unstructured":"Portevin D, Moukambi F, Clowes P, et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis, 2014,14(10):931\u2013938","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2649_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jinf.2015.07.009","volume":"71","author":"E Petruccioli","year":"2015","unstructured":"Petruccioli E, Petrone L, Vanini V, et al. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis. J Infect, 2015,71(5):526\u2013533","journal-title":"J Infect"},{"issue":"4","key":"2649_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10875-010-9418-1","volume":"30","author":"J Jiang","year":"2010","unstructured":"Jiang J, Wang X, Wang X, et al. Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis. J Clin Immunol, 2010,30(4): 566\u2013573","journal-title":"J Clin Immunol"},{"issue":"3","key":"2649_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nm.2299","volume":"17","author":"A Harari","year":"2011","unstructured":"Harari A, Rozot V, Bellutti Enders F, et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med, 2011,17(3):372\u2013376","journal-title":"Nat Med"},{"key":"2649_CR16","doi-asserted-by":"publisher","first-page":"17918","DOI":"10.1038\/srep17918","volume":"5","author":"Q Yang","year":"2015","unstructured":"Yang Q, Xu Q, Chen Q, et al. Discriminating Active Tuberculosis from Latent Tuberculosis Infection by flow cytometric measurement of CD161-expressing T cells. Sci Rep, 2015,5:17918","journal-title":"Sci Rep"},{"key":"2649_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3389\/fimmu.2017.00968","volume":"8","author":"C Riou","year":"2017","unstructured":"Riou C, Berkowitz N, Goliath R, et al. Analysis of the Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals. Front Immunol, 2017,8:968","journal-title":"Front Immunol"},{"key":"2649_CR18","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3389\/fimmu.2018.02427","volume":"9","author":"R Lubbers","year":"2018","unstructured":"Lubbers R, Sutherland JS, Goletti D, et al. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis. Front Immunol, 2018,9:2427","journal-title":"Front Immunol"},{"issue":"1","key":"2649_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12967-018-1572-x","volume":"16","author":"S Wang","year":"2018","unstructured":"Wang S, Li Y, Shen Y, et al. Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB. J Transl Med, 2018,16(1):206","journal-title":"J Transl Med"},{"key":"2649_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fmicb.2018.00602","volume":"9","author":"N Sabir","year":"2018","unstructured":"Sabir N, Hussain T, Shah SZA, et al. miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy. Front Microbiol, 2018,9:602","journal-title":"Front Microbiol"},{"issue":"6","key":"2649_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/infdis\/jit265","volume":"208","author":"KM Pollock","year":"2013","unstructured":"Pollock KM, Whitworth HS, Montamat-Sicotte DJ, et al. T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis, 2013,208(6):952\u2013968","journal-title":"J Infect Dis"},{"issue":"6","key":"2649_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tube.2012.06.005","volume":"92","author":"X Wang","year":"2012","unstructured":"Wang X, Jiang J, Cao Z, et al. Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis. Tuberculosis (Edinb), 2012,92(6):513\u2013520","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"2649_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41564-019-0380-2","volume":"4","author":"E MacLean","year":"2019","unstructured":"MacLean E, Broger T, Yerlikaya S, et al. A systematic review of biomarkers to detect active tuberculosis. Nat Microbiol, 2019,4(5):748\u2013758","journal-title":"Nat Microbiol"},{"key":"2649_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijid.2017.01.025","volume":"56","author":"S Yerlikaya","year":"2017","unstructured":"Yerlikaya S, Broger T, MacLean E, et al. A tuberculosis biomarker database: the key to novel TB diagnostics. Int J Infect Dis, 2017,56:253\u2013257","journal-title":"Int J Infect Dis"},{"issue":"2","key":"2649_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7150\/ijbs.5613","volume":"9","author":"X Zhou","year":"2013","unstructured":"Zhou X, Michal JJ, Zhang L, et al. Interferon induced IFIT family genes in host antiviral defense. Int J Biol Sci, 2013,9(2):200\u2013208","journal-title":"Int J Biol Sci"},{"key":"2649_CR26","doi-asserted-by":"publisher","first-page":"e14228","DOI":"10.7554\/eLife.14228","volume":"5","author":"MD Daugherty","year":"2016","unstructured":"Daugherty MD, Schaller AM, Geballe AP, et al. Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals. Elife, 2016,5:e14228","journal-title":"Elife"},{"issue":"2","key":"2649_CR27","doi-asserted-by":"publisher","first-page":"e1007609","DOI":"10.1371\/journal.ppat.1007609","volume":"15","author":"D Li","year":"2019","unstructured":"Li D, Swaminathan S. Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system. PLoS Pathog, 2019,15(2):e1007609","journal-title":"PLoS Pathog"},{"issue":"7","key":"2649_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ni.2048","volume":"12","author":"A Pichlmair","year":"2011","unstructured":"Pichlmair A, Lassnig C, Eberle CA, et al. IFIT1 is an antiviral protein that recognizes 5\u2019-triphosphate RNA. Nat Immunol, 2011,12(7):624\u2013630","journal-title":"Nat Immunol"},{"issue":"5","key":"2649_CR29","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.4049\/jimmunol.1100963","volume":"187","author":"XY Liu","year":"2011","unstructured":"Liu XY, Chen W, Wei B, et al. IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. J Immunol, 2011,187(5):2559\u20132568","journal-title":"J Immunol"},{"issue":"6","key":"2649_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/1389203720666190405101138","volume":"20","author":"F Ceciliani","year":"2019","unstructured":"Ceciliani F, Lecchi C. The immune functions of alpha1 acid glycoprotein. Curr Protein Pept Sci, 2019,20(6):505\u2013524","journal-title":"Curr Protein Pept Sci"},{"issue":"5","key":"2649_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/blood-2013-10-529628","volume":"123","author":"A Rocanin-Arjo","year":"2014","unstructured":"Rocanin-Arjo A, Cohen W, Carcaillon L, et al. A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential. Blood, 2014, 123(5):777\u2013785","journal-title":"Blood"},{"issue":"1","key":"2649_CR32","first-page":"25","volume":"71","author":"PA Ganz","year":"1983","unstructured":"Ganz PA, Shell WE, Tokes ZA. Evaluation of a radioimmunoassay for alpha 1-acid glycoprotein to monitor therapy of cancer patients. J Natl Cancer Inst, 1983,71(1):25\u201330","journal-title":"J Natl Cancer Inst"},{"key":"2649_CR33","doi-asserted-by":"publisher","first-page":"23695","DOI":"10.1038\/srep23695","volume":"6","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Li Z, Sun Z, et al. S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK\/T cell lymphoma patients treated with pegaspargase\/gemcitabine. Sci Rep, 2016,6:23695","journal-title":"Sci Rep"},{"issue":"3","key":"2649_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/clinchem\/41.3.472","volume":"41","author":"K Fassbender","year":"1995","unstructured":"Fassbender K, Fassbender M, Schaberg T, et al. Glycosylation of alpha 1-acid glycoprotein in bacterial lung infections: distinct pattern in tuberculosis. Clin Chem, 1995,41(3):472\u2013473","journal-title":"Clin Chem"},{"issue":"2","key":"2649_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cmi.2018.07.017","volume":"25","author":"VS Santos","year":"2019","unstructured":"Santos VS, Goletti D, Kontogianni K, et al. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis. Clin Microbiol Infect, 2019,25(2):169\u2013177","journal-title":"Clin Microbiol Infect"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-022-2649-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T19:16:40Z","timestamp":1672600600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-022-2649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1007\/s11596-022-2649-6","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}